Literature DB >> 9233455

Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.

F Dromer1, L Improvisi, B Dupont, M Eliaszewicz, G Pialoux, S Fournier, V Feuillie.   

Abstract

BACKGROUND: Fluconazole resistance has emerged among Candida albicans isolates and has been associated with the prolonged or repeated use of the drug. This study was designed to discover whether transmission of oral isolates could occur between sexual partners and thereby explain fluconazole resistance in patients never treated with the drug.
MATERIALS AND METHODS: The oral flora of 10 HIV-infected couples (five heterosexual and five homosexual) were studied. In vitro susceptibility testing and genotyping (restriction fragment length polymorphism with EcoRI and HinfI) were used to delineate strain relatedness for 230 clones (five clones per sample, one to four samples per patient).
RESULTS: The genetic diversity of the clones with one DNA subtype was specific to a given patient or a given couple, except in one case in which unrelated patients shared clones of the same genotype. The persistence of clones between partners was stable over time in six out of 10 couples and only transient in one couple. Fluconazole resistance in isolates from patients who had never been treated with azoles was associated in three patients with the first episode of oropharyngeal candidiasis and treatment failure.
CONCLUSION: The observation that couples tended to share genetically indistinguishable clones was highly suggestive of transmission between partners. This phenomenon may, in part, explain the pathogenesis of oropharyngeal candidiasis and the increased frequency of fluconazole resistance both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233455     DOI: 10.1097/00002030-199709000-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 2.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells.

Authors:  S L Newman; A Holly
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Enhanced killing of Candida albicans by human macrophages adherent to type 1 collagen matrices via induction of phagolysosomal fusion.

Authors:  Simon L Newman; Bindu Bhugra; Angela Holly; Randal E Morris
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.

Authors:  F C Odds; A D Davidson; M D Jacobsen; A Tavanti; J A Whyte; C C Kibbler; D H Ellis; M C J Maiden; D J Shaw; N A R Gow
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis.

Authors:  F M Müller; M Kasai; A Francesconi; B Brillante; M Roden; J Peter; S J Chanock; T J Walsh
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.

Authors:  Natalya U Makarova; V V Pokrowsky; A V Kravchenko; L V Serebrovskaya; Michael J James; Michael M McNeil; Brent A Lasker; David W Warnock; Errol Reiss
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients.

Authors:  S Y Li; Y L Yang; K W Chen; H H Cheng; C S Chiou; T H Wang; T L Lauderdale; C C Hung; H J Lo
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

9.  In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs.

Authors:  S Magaldi; S Mata; C Hartung; G Verde; L Deibis; Y Roldán; C Marcano
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

10.  The weapon potential of a microbe.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Trends Microbiol       Date:  2004-06       Impact factor: 17.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.